A pioneering study has uncovered the complex and dual roles of neutrophils in cancer development, demonstrating their remarkable ability to both stimulate and suppress tumor growth.
XFOR READ THE FULL XFOR RESEARCH REPORT Business Update Licensing Agreement with Norgine Includes €28.5 Million Upfront Payment On January 13, 2025, X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) announced ...